2009
DOI: 10.1016/j.physbeh.2008.11.018
|View full text |Cite
|
Sign up to set email alerts
|

No effect of different estrogen receptor ligands on cognition in adult female monkeys

Abstract: Many studies in women and animal models suggest that estrogens affect cognitive function. Yet, the mechanisms by which estrogens may impact cognition remain unclear. The goal of the present study was to assess the effects of different estrogen receptor (ER) ligands on cognitive function in adult ovariectomized female rhesus monkeys. The monkeys were tested for 6 weeks on a battery of memory and attentional tasks administered on a touchscreen: the object, face, and spatial versions of the Delayed Recognition Sp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 65 publications
0
10
0
Order By: Relevance
“…Beginning on day 9 of the luteal phase (mid-late) macaques (n=14) monkeys were randomly assigned to four treatment groups: Control (no treatment, n=4), Antide to induce early onset of luteal regression as previously reported [24] (GnRH antagonist, 3mg/kg/day; n=4), Antide + progestin replacement with R5020 (synthetic progestin, 2.5 mg/day [24], PerkinElmer Inc, n=3), or Antide + estrogen replacement with two specific estrogen receptor (ER) agonists (ER1, propyl-pyrazole-triol, PPT; ER2, diarylpropionitrile, DPN; both 0.15 mg/kg/day, Tocris Bioscience [30], n=3). The CL was collected from anesthetized females on day 12 of the luteal phase, after 3 days of treatment.…”
Section: Collection Following Induced Luteal Regressionmentioning
confidence: 64%
“…Beginning on day 9 of the luteal phase (mid-late) macaques (n=14) monkeys were randomly assigned to four treatment groups: Control (no treatment, n=4), Antide to induce early onset of luteal regression as previously reported [24] (GnRH antagonist, 3mg/kg/day; n=4), Antide + progestin replacement with R5020 (synthetic progestin, 2.5 mg/day [24], PerkinElmer Inc, n=3), or Antide + estrogen replacement with two specific estrogen receptor (ER) agonists (ER1, propyl-pyrazole-triol, PPT; ER2, diarylpropionitrile, DPN; both 0.15 mg/kg/day, Tocris Bioscience [30], n=3). The CL was collected from anesthetized females on day 12 of the luteal phase, after 3 days of treatment.…”
Section: Collection Following Induced Luteal Regressionmentioning
confidence: 64%
“…The delayed recognition span test (DRST) followed Lacreuse et al (). DRST is a test of simple working memory that is sensitive to hippocampal lesions in monkeys (Beason‐Held et al, ).…”
Section: Methodsmentioning
confidence: 99%
“…We tested 2.5‐ to 3‐year‐old children who would be expected to be in the transitional zone for success on the door task. Children were tested on the door task and four other tasks, a test of spatial working memory (three boxes stationary, Diamond et al, ), a test of nonspatial working memory (three boxes scrambled, Diamond et al, ), a test of inhibitory control (three pegs task, Balamore & Wozniak, ; Diamond et al, ), and a test of working memory that simply entailed maintaining information over a delay (delayed recognition memory span test, Lacreuse, Wilson, & Herndon, ), in order to determine if children's abilities in any of these domains could be associated with performance on the Berthier et al door task. These tests, with the exception of the working memory test that entailed simple maintenance of information, have been associated with the function of prefrontal cortex (Diamond et al, ; Petrides, ).…”
Section: Introductionmentioning
confidence: 99%
“…In this case, the difference in the strain of rats used in the two studies (Long Evans versus Sprague Dawley, respectively) may have contributed to the discrepancies, as other conditions were similar. In general, species, age, and duration of treatment may also be important factors, as chronic treatment of either ERα or ERα agonists enhances cognition in young rats (Hammond et al, 2009), impair cognition in middle-aged rats (Neese et al, 2010), and has no cognitive effects in adult monkeys (Lacreuse et al, 2009). These studies underscore the complexity of factors involved in using SERMs and warrant further investigation of potential parameters that impact cognitive outcome.…”
Section: Hormone Receptors and The Cognitive Effects Of Hormonesmentioning
confidence: 99%